Insight: Big Pharma braces for retirement of favorite regulator

October 10, 2013 5:08 AM

13 0

Insight: Big Pharma braces for retirement of favorite regulator

WASHINGTON (Reuters) - The retirement of Dr. Janet Woodcock as head of the Food and Drug Administration's pharmaceutical division is at least a year away, but already the industry she regulates is worrying about who will replace her.

Over the past 20 years Woodcock, who is 65, has reshaped the drug approval process, relaxing the criteria needed for certain drugs to reach the market - especially those that represent scientific breakthroughs. Last year, the agency approved 39 new drugs, the most since 1996.

Read more

To category page

Loading...